Document:

f1012gex10ii_newtech.htm

    Exibit
10.2

     

    Date:_____ ,
2009

    

    NewTech
Enterprise Management, Inc.

    c/o Steve
Zhu

    CitiGroup
Tower 14/F,

    33 Hua
Yuan Shi Qiao Road

    Shanghai
Pudong New Area

    PRC,
200120

     

    Re:  Stock Purchase
Agreement

     

    Dear
Sirs:

    

    This agreement sets forth the terms on
which the undersigned (the “Purchaser”) agrees to purchase shares (the “Shares”)
of common stock, par value $.001 per share (“Common Stock”) of NewTech
Enterprise Management, Inc., a Delaware corporation, at a purchase price per
Share of RMB  (the “Purchase Price per Share”).

     

    In consideration of the mutual
covenants and agreements set forth herein, the Company and the Purchaser hereby
agree as follows:

     

    1. The
Purchaser hereby agrees to purchase from the Company, and the Company agrees to
sell to the Purchaser, the number of Shares set forth on the signature page of
this Agreement at the Purchase Price per Share.  The total purchase
price (the “Purchase Price”) for the Shares subscribed for by the Purchaser is
set forth on the signature page of this Agreement.

     

    2. Payment
of the Purchase Price shall be made by wire transfer in accordance by wire
transfer in accordance with the instructions from the Company or otherwise in
accordance with instructions from the Company.   The Company will
have the Shares issued as soon as practical after its receipt of payment of the
Purchase Price, it being understood that, at present, the Common Stock is not
certificated, which means that the Company is not issuing stock certificate for
the Shares and the Purchaser’s ownership in the Shares is reflected on the
Company’s books and records.

     

    3. The
Company is offering a maximum of 50,000 shares of Common Stock at the Purchase
Price per Share on a best efforts basis, with no minimum number of Shares being
sold.  As a result, the Purchaser understands that it is possible that
the Company will not receive any proceeds from the sale of Shares other than the
purchase price of the Shares previously sold by the Company, if any, and the
Purchase Price of the Shares being purchased by the Purchaser. The Company may
offer the Shares during the Subscription Period.  The Subscription
Period is the period ending on September 15, 2009, which date may be extended by
the Company on one or more occasions, for a maximum of 60 additional
days.

     

    4. The
Purchaser hereby represents, warrants, covenants and agrees as
follows:

     

    (a) The
Purchaser understands that the offer and sale of the Shares is being made only
by means of this Agreement.  The Purchaser understands that the
Company has not authorized the use of, and the Purchaser confirms that he is not
relying upon, any other information, written or oral, other than material
contained in this Agreement and in material that has been publicly filed by the
Company with the Securities and Exchange Commission (the
“Commission”).  The Purchaser is aware that
the purchase of the Shares involves a high degree of risk and that the Purchaser
may sustain, and has the financial ability to sustain, the loss of his entire
investment, understands that no assurance can be given that the Company will be
profitable in the future.  

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        
The Purchaser understands
that Company presently does not have any business activities and the Company
cannot give any assurance that it will ever engage in any business
activities.  The Company’s business plan is based on the future
acquisition by the Company of another company or business.  The
Purchaser understands that the Company has given no assurance that the Company
will even be able to acquire a business and that, in the event that the Company
does acquire a business, the Purchaser cannot give any assurance that the
acquired business will ever be profitable.  In the event that the
Company may make an acquisition, the Purchase recognizes that he or she may
suffer very significant dilution in his or her interest in the
Company.  Further, in order for the Company to complete any
acquisition, the Company anticipates that it will require financing both to make
the acquisition and to provide working capital after the offering, and the
Company cannot give any assurance that any financing will be available, that, if
financing is available, it will be on reasonable terms, that it will be adequate
or that it will not result in additional very significant dilution in
Purchaser’s interest in the Company. The Purchaser understands that there is no
market for the Common Stock and, unless the Company makes an acquisition and
thereafter makes all required filings with the Commission, there may never be a
market for the Shares.  Further, even if, in the future, there is a
market for the Shares, the market may be very thin and that the Purchaser may be
unable to sell his or her Shares, and the Purchaser may not be able to sell his
or her shares until more than one year after the Company makes the required
filing with the Commission with respect to the acquisition. Furthermore, in
subscribing for the Shares, the Purchaser acknowledges that he or she is not
relying upon any projections or any statements of any kind relating to future
revenue, earnings, operations or cash flow or acquisitions in purchasing the
Shares.

    

     

    (b) The
Purchaser represents that he or she has such knowledge and experience in
financial and business matters as to enable the Purchaser to understand the
nature and extent of the risks involved in purchasing the Shares.  The
Purchaser is fully aware that such investments can and sometimes do result in
the loss of the entire investment.  The Purchaser has engaged his own
counsel and accountants to the extent that he deems it necessary.

     

    (c) Purchaser
is not acquiring the Shares as a result of, and will not itself engage in, any
"directed selling efforts" (as defined in Regulation S) in the United States in
respect of the Shares which would include any activities undertaken for the
purpose of, or that could reasonably be expected to have the effect of,
conditioning the market in the United States for the resale of the Shares;
provided, however, that the Purchaser may sell or otherwise dispose of the
Shares pursuant to registration thereof under the Securities Act and any
applicable state and provincial securities laws or under an exemption from such
registration requirements.

     

    (d) The
Purchaser acknowledges and agrees that none of the Shares have been registered
under the Securities Act, or under any state securities or "blue sky" laws of
any state of the United States, and, unless so registered, may not be offered or
sold in the United States or, directly or indirectly, to U.S. Persons, as that
term is defined in Regulation S, except in accordance with the provisions of
Regulation S, pursuant to an effective registration statement under the
Securities Act, or pursuant to an exemption from, or in a transaction not
subject to, the registration requirements of the Securities Act and in each case
in accordance with applicable state securities laws.

     

    (e) The
Purchaser acknowledges and agrees that the Issuer will refuse to register any
transfer of the Shares not made in accordance with the provisions of Regulation
S, pursuant to an effective registration statement under the Securities Act or
pursuant to an available exemption from the registration requirements of the
Securities Act and in accordance with applicable state and provincial securities
laws.

     

    (f) The
Purchaser represents and warrants that no broker or finder was involved directly
or indirectly in connection with his or her purchase of the Shares pursuant to
this Agreement. The Purchaser shall indemnify the Issuer and hold it harmless
from and against any manner of loss, liability, damage or expense, including
fees and expenses of counsel, resulting from a breach of the Purchaser’s
warranty contained in this Paragraph 5(f).

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    (g) The
Purchaser understands that he or she has no registration rights with respect to
the Shares.

     

    (h) The
Purchaser is not a citizen or resident of the United States.

     

    (i) The
Purchaser is acquiring the Shares for his or her own account, for investment
only and not with a view to resale or distribution and, in particular, it has no
intention to distribute either directly or indirectly any of the Shares in the
United States or to U.S. Persons (except in accordance with the regulation of
the Commission), and no other person has a direct or indirect beneficial
interest in such Shares;

     

    (j) The
Purchaser is not an underwriter of, or dealer in, the common stock of the
Company, nor is the Purchaser participating, pursuant to a contractual agreement
or otherwise, in the distribution of the Shares.

     

    (k) The
Purchaser was not induced to invest by any form of general solicitation or
general advertising including, but not limited to, the following: (i) any
advertisement, article, notice or other communication published in any
newspaper, magazine or similar media or broadcast over the news or radio; and
(ii) any seminar or meeting whose attendees were invited by any general
solicitation or advertising.

     

    (l) No person
has made to the Purchaser any written or oral representations:

     

    (i) that any
person will resell or repurchase any of the Shares;

     

    (ii) that any
person will refund the purchase price of any of the Shares;

     

    (iii) as to the
future price or value of any of the Shares; or

     

    (iv) that any
of the Shares will be listed and posted for trading on any stock exchange or
automated dealer quotation system or that application has been made to list and
post any of the Shares of the Issuer on any stock exchange or automated dealer
quotation system.

     

    (m) The
Purchaser will not transfer any Shares except in compliance with all applicable
federal and state securities laws and regulations, and, in such connection, the
Company may request an opinion of counsel reasonably acceptable to the Company
as to the availability of any exemption.

     

    (n) The
Purchaser represents and warrants that the address set forth on the signature
page is his true and correct address, and understands that the Company will rely
on this representation.

     

    (o) The
Purchaser is not an associate of a registered broker-dealer.

     

    (p) If the
Purchaser is a corporation, partnership, trust or other entity, the Purchaser
represents and that (i) it is authorized and otherwise duly qualified to
purchase and hold the Shares; (ii) this Subscription Agreement has been duly and
validly authorized, executed and delivered and constitutes the legal, binding
and enforceable obligation of the Purchaser, and (iii) the individual who
executed this Agreement on behalf of the Purchaser is authorized to do
so.

     

    (q) The
Purchaser acknowledges that the Company has made no representation or warranties
except as expressly set forth in this Agreement.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    5. The
Company represents and warrants to the Purchaser that the issuance of the Shares
has been duly authorized by all necessary corporate action and, when issued
pursuant to this Agreement upon payment of the Purchase Price of the Shares, the
Shares will be duly and validly authorized and issued, fully paid and
non-assessable.

     

    6. All
notices provided for in this Agreement shall be in writing signed by the party
giving such notice, and delivered personally or sent by overnight courier or
messenger against receipt thereof or sent by registered or certified mail (air
mail if overseas), return receipt requested or by telecopier if receipt of
transmission is confirmed by the recipient or if transmission is confirmed by
mail as provided in this Section 6.  Notices shall be deemed to have
been received on the date of receipt.  Notices shall be sent to the
Company at NewTech Enterprise Management, Inc. at the address set forth as the
beginning of this Agreement to the attention of the person executing this
Agreement on behalf of the Company and to the Purchaser at his address and
telecopier number set forth on the records of the Company.  A copy of
any notice to the Company shall be sent to Sichenzia Ross Friedman Ference LLP,
61 Broadway, 32nd
floor, New York, New York 10006, Attention Asher S. Levitsky P.C., telecopier:
(212) 930-9725, e-mail: alevitsky@srff.com.  Either
party may change the address or person to whom notice should be by notice given
in the manner set forth in this Section 6.

     

    7. (a)  This
Agreement constitutes the entire agreement between the parties relating to the
subject matter hereof, superseding any and all prior or contemporaneous oral and
prior written agreements, understandings and letters of intent.  This
Agreement may not be modified or amended nor may any right be waived except by a
writing which expressly refers to this Agreement, states that it is a
modification, amendment or waiver and is signed by all parties with respect to a
modification or amendment or the party granting the waiver with respect to a
waiver.  No course of conduct or dealing and no trade custom or usage
shall modify any provisions of this Agreement.

     

    (b) This
Agreement and the rights of the parties shall be governed by and construed in
accordance with the laws of the State of New York applicable to contracts made
and to be performed entirely within such State.  Each party hereby (i)
consent to the exclusive jurisdiction of the United States District Court for
the Southern District of New York and state courts of the State and County of
New York in any action relating to or arising out of this Agreement, (ii) agrees
that any process in any such action may be served upon it either (x) by
certified or registered mail, return receipt requested, or by hand delivery or
overnight courier service which obtains evidence of delivery, with the same full
force and effect as if personally served upon such party in New York City or (y)
any other manner of service permitted by law, and (iii) waives any claim that
the jurisdiction of any such tribunal is not a convenient forum for any such
action and any defense of lack of in personam jurisdiction with respect thereto.
The parties executing this
Agreement agree to waive trial by jury. The prevailing party shall be
entitled to recover from the other party its reasonable attorney’s fees and
costs.

     

    (c) In the
event that any provision of this Agreement is invalid or unenforceable under any
applicable statute or rule of law, then such provision shall be deemed
inoperative only to the extent that it may conflict therewith and shall be
deemed modified to conform with such statute or rule of law. Any such provision
which may prove invalid or unenforceable under any law shall not affect the
validity or enforceability of any other provision of any agreement.

     

    (d) This
Agreement shall be binding upon and inure to the benefit of the parties hereto,
and their respective successors and permitted assigns.

     

    (e) This
Agreement may be executed in two or more counterparts, each of which shall be
deemed an original but all of which together shall constitute one and the same
document.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

    (f) The
various representations, warranties, and covenants set forth in this Agreement
or in any other writing delivered in connection therewith shall survive the
issuance of the Shares.

     

    Please confirm your agreement with the
foregoing by signing this Agreement where
indicated.     
          

     

    Very truly yours,

    

    
      	
              SUBSCRIBER**:

            	
              CO-SUBSCRIBER**:

            
	
               

              _______________________________

              Signature
      of Purchaser

            	
               

              ___________________________________

              Signature
      of Co-Purchaser

            
	
               

              _______________________________

              Name
      of Purchaser [please print]

            	
               

              ___________________________________

              Name
      of Co-Purchaser [please print]

            
	
               

              _______________________________   

              Address
      of Purchaser

            	
               

              ___________________________________

              Address
      of Co-Purchaser

            
	
               

              _______________________________

              Social
      Security or Taxpayer

              Identification
      Number of Purchaser

               

            	
               

              ___________________________________

              Social
      Security or Taxpayer Identification

              Number
      of Co-Purchaser

            
	
               

              ________________________________________________________

              Name
      of Holder(s) as it should appear on the Company’s records *

               

            
	
              *Please
      provide the exact names

              (1)      For
      individuals, print full name of subscriber.

              (2)      For
      joint, print full name of subscriber and all co-subscribers.

              (3)      For
      corporations, partnerships, LLC, print full name of entity, including
      “&,” “Co.,” “Inc.,” “LLC,” “LP,” etc.

              (4)      For
      Trusts, print trust name (please contact your trustee for the exact name
      that should appear on the Company’s records).

            
	
               

              Total
      Purchase Price of Shares subscribed for:

              RMB __________________

              Number
      of Shares subscribed
      for: _________________                                                           

            	 
      

    

    

     

    Accepted
this___day of _________, 2009

     

    NewTech
Enterprise Management, Inc.

    

    

    
      	
              By:___________________________

            

    

    Name:

    Title:

    

    This
subscription is accepted for the full amount subscribed for unless a lesser
amount is set forth below.

    

    Amount
Accepted:$                                                                

    

    
      
        
        

      

      
        5fs1ex10iv_kraigbio.htm

    Exhibit
10.4

    CALM
SEAS CAPITAL, LLC

    377 S.
NEVADA ST.

    CARSON
CITY, NEVADA 89703

    

    September
14, 2009

    

    Kim
Thompson, CEO

    Kraig
Biocraft Laboratories, Inc.

    120 N.
Washington Square, Suite 805

    Lansing,
MI 48933

    

    In Re: Proposed Equity Line Transaction
- Amended Term Sheet

    

    Dear Mr.
Thompson:

    

    This
Letter is to serve as a binding Memorandum of Understanding for an Equity Line
transaction by Calm Seas Capital, LLC (“Investor”) and Kraig Biocraft
Laboratories, Inc. (the “Company”) in accordance with the terms and conditions
on the attached Amended Term Sheet, which is hereby incorporated herein by
reference. You will note that the Term Sheet contains certain covenants by, and
limitations upon, you, as the Company’s primary officer. If this transaction is
acceptable to the Company, on the one hand, and to you, individually, on the
other hand, please so indicate by signing and dating where indicated below and
returning this Letter MOU to us.  In addition, please initial each of
the pages of the attached Term Sheet and return it to us with the accepted
Amended Letter MOU.

    

    Yours
truly,

    CALM
SEAS CAPITAL, LLC

    

    

    

    By: 
/s/  Michael McCarthy   

    

    

    AGREEMENT
and ACCEPTANCE

    

    The
foregoing Amended Letter MOU together with the attached and incorporated Amended
Term Sheet is approved as of this 14th day of September,
2009:

    

    KRAIG
BIOCRAFT LABORATORIES, INC.

    

    

    By:        /s/Kim
Thompson

         Kim
Thompson, CEO

    

    KIM
THOMPSON (individually)

    

              /s/Kim
Thompson

     

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    KRAIG
BIOCRAFT LABORATORIES, INC.

    

    AMENDED
TERM SHEET

    (September
14, 2009)

    

    
      	
              Issuer:

            	
              Kraig
      Biocraft Laboratories, Inc. (OTC BB:
KBLB)

            

    

    

    
      	
              Offering:

            	
              Up
      to $1,000,000 in shares of Common
Stock

            

    

    

    
      	
              Investor(s):

            	
              Calm
      Seas Capital, LLC, as lead investor, and associated
    entities

            

    

    

    
      	
              Bridge
      Investment:

            	
              $120,000,
      of which $100,000 shall be paid within five (5) days of the acceptance of
      this Term Sheet (“Commitment Date”) and the balance shall be paid prior to
      the filing of Form S-1 with the Securities and Exchange Commission, for
      the purchase of Units consisting of Convertible Debentures and cashless
      Common Stock Purchase Warrants (see below). Payments of the bridge
      investment shall be by wire
transfer

            

    

    

    Convertible

    
      	
              Debentures:

            	
              The
      debentures shall be in the face amount of $10,000 each, mature on December
      31, 2010, bear interest at the rate of 5% simple interest per annum,
      payable at maturity or convertible with the principal, and the principal
      and interest shall be convertible at the option of the holder at a fixed
      price of $.018 per share; the debentures cannot be repaid from the
      proceeds of the Equity Line

            

    

    

    
      	
              Warrants:

            	
              Each
      debenture shall have a warrant attached exercisable for the purchase of
      500,000 shares; the warrants shall expire on December 31, 2011, have a
      cashless exercise provision, and be exercisable at a fixed price of
      $.02

            

    

    

    
      	
              Execution
      Date:

            	
              The
      Execution Date is the date on which the final documents for the Equity
      Line of Credit are signed by both the Company and the
      Investor(s)

            

    

    

    
      	
              Structure:

            	
              Equity
      Line of Credit, with monthly puts (1 per month) against the Commitment
      Amount, during the “Term”

            

    

    

    
      	
              Use
      of Proceeds:

            	
              Working
      capital, as more specifically described in the schedule and on the
      timeline to be attached to the final documents as the “Schedule of Use of
      Proceeds”

            

    

    

    
      	
              Term:

            	
              The
      Term shall be that period commencing with the Effective Date and ending on
      the earlier of (a) the drawing down of the entire Commitment Amount or (b)
      that date 24 months after the Effective
Date

            

    

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    Commitment

    
      	
              Amount:

            	
              The
      Investor(s) shall commit to purchase up to $1,000,000 of the Company’s
      Common Stock over the course of no more than 24 months (the “Commitment
      Period”) after the date a registration statement for the resale of the
      Common Stock has been declared effective (the “Effective Date”) by the
      U.S. Securities and Exchange Commission
(“SEC”)

            

    

    

    
      	
              First
      Put:

            	
              The
      Company may issue its first “Put Notice” during the first 5 business days
      of the month succeeding the month in which the Effective Date
      occurs

            

    

    

    Calculation
of

    
      	
              Put
      Amount:

            	
              Prior
      to the end of each calendar month, the Company shall determine its working
      capital needs (consistent with the Schedule of Use of Proceeds) and,
      subject to the Put Ceiling and Put Floor, by the fifth business day of the
      following month shall deliver to Investor(s) a “Put Notice” for the
      necessary amount; the date of delivery of the Put Notice shall be the “Put
      Date”

            

    

    

    
      	
              Put  Ceiling:

            	
              The
      maximum amount which the Company shall be entitled to request by each Put
      shall be the lesser of (a) $75,000 or (b) 200% of the average daily volume
      (“ADV”) multiplied by the average of the daily closing prices for the ten
      (10) trading days immediately preceding the Put Date.  The ADV
      shall be computed using the 10 trading days prior to the Put
      Date.

            

    

    

    
      	
              Put
      Floor:

            	
              The
      Company shall automatically withdraw that portion of the Put Notice amount
      if the Market Price with respect to that put does not meet the Minimum
      Acceptable Price, which is defined as 75% of the average closing “bid”
      price for the Common Stock for the 10 trading days prior to the Put
      Date

            

    

    

    Put by
Mutual

    
      	
              Agreement:

            	
              Notwithstanding
      the ceiling for each Put, as described above, at any time either as a part
      of a monthly Put or as an additional Put(s) during a month, the Company
      may request permission to request funds in excess of the Put Ceiling for
      such month and may deliver to Investor(s) a Put or Puts in excess of the
      Put Ceiling, which Put or Puts Investor(s) may fund, in its/their sole
      discretion, subject to the terms and conditions herein applicable to the
      monthly Puts.

            

    

    

    
      	
              Pricing
      Period:

            	
              The
      five (5) consecutive trading days immediately after the Put
      Date.

            

    

    

    
      	
              Market
      Price:

            	
              The
      lowest closing “bid” price of the Common Stock during the Pricing
      Period.

            

    

    

    
      	
              Purchase
      Price:

            	
              The
      purchase price shall be eighty percent (80%) of the Market
      Price.

            

    

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    
      	
              Put
      Closing Date:

            	
              7
      business days after the Put Date; the Investor shall make the investment
      required by the Put Notice, subject to the Put Ceiling, by the 7th
      business day after the Put Notice, not counting the day the notice is
      given.  Payments of the Puts shall be made by wire
      transfer

            

    

    

    Registration

    
      	
              Statement:

            	
              The
      Investor will work with the Company to have a registration statement
      covering the Common Stock (or a portion thereof if there is a Rule 415
      cutback - see below) prepared and filed by corporate counsel as
      recommended by the Investor, within 75 days after the Execution
      Date.  Such Registration Statement shall be prosecuted with all
      due speed to be declared effective within 120 days after the Effective
      Date.

            

    

    

    
      	
              Expenses:

            	
              The
      Investor agrees to pay all expenses related to the preparation of the
      final documents to be signed on the Execution Date and all expenses
      related to the filing and prosecution of the Registration
      Statement.  The Investor will select counsel of its choice to
      prepare the documents.

            

    

    

    
      	
              Commitment
      Fee:

            	
              Waived

            

    

    

    Rule
415

    
      	
              Cutback:

            	
              In
      the event that the SEC objects to the number of shares proposed to be
      registered, the Company shall use its best efforts to register the maximum
      number of shares permissible by the SEC to retain the status of the
      offering as a secondary offering under SEC Rule
  415.

            

    

    

    Equity
Issuance

    
      	
              Restriction:

            	
              The
      Company agrees not to issue any equity or equity equivalents (exercisable
      or convertible into equity securities), including those on Form S-8,
      (other than those hereunder) in an amount which would exceed 5% of the
      Company’s issued and outstanding shares without the prior written consent
      of the Investor.  This Equity Issuance Restriction will remain
      in effect until the earlier of (a) thirty (30) days after the issuance to
      Investor of all registered Common Stock, (b) thirteen (13) months after
      the effective date of the Registration Statement, or (c) the termination
      of this Equity Line of Credit

            

    

    

    
      	
              Covenants:

            	
              1.  During
      the Term, the Company shall maintain the effectiveness of the Registration
      Statement

              2.  During
      the Term, the Company shall maintain its status as a company trading on
      the OTC BB

              3.  During
      the Term, the Company shall timely file all required SEC
      reports

              4.  Proceeds
      from the Puts shall be used only as set forth in the Schedule of Use of
      Proceeds without the written approval of a variation by the
      Investor(s)

              5.  During
      the Term, the Company shall maintain its existing R&D contracts and
      relationships

              6.  Company
      shall maintain a contractual relationship for the performance of financial
      public relations services for a period of 36 months from the effective
      date, with the extent of the costs of such services to be proportional to
      the size and growth of the Company

            

    

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    
 

    
      	
              Short
      Sales:

            	
              During
      the Term, the Investor agrees not to engage in any short selling of the
      Company’s Common Stock

            

    

    

    
      	
              Exclusivity:

            	
              From
      the date of the execution of this Amended Term Sheet until the Effective
      Date, the Company shall not pursue any other transaction of the nature
      contemplated herein with any other person unless and until good faith
      negotiations with the Investor have been
  terminated.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}]]